@junglejava1 I'm familiar enough with the psychedelic sector to be confident in my own picks, but I've picked up some $PSIL based on the fact that it offers exposure to a few companies that I'm unable to buy without intense fees.
Bottom line? It's been fun.
I still think the market at large is overvalued- the thing keeping me married to risk is ceaseless contrarianism.
[The same contrarianism that's keeping me from pursuing a traditional finance career]
[[That, and I might be dumb as hell]]
Anyway!
I'm not sure what's next; I ended up getting a job, so obviously I've got the ability to keep accumulating. The next milestone would be breaking the $25k mark in order to allow for PDT moves, and I guess after that it's ~$100k+ in order to be a 'qualified investor.'
Since I began in February with less than $2k, I started out with a cash account.
First goal: swing trade the cash account [~$1600] until I'm able to open a margin account. I reached this goal on June 15th without allocating additional funds to the portfolio.
#History: May 1971 #Microgram https://t.co/IDux1pUYnv
Announced implementation of fateful Controlled Substances Act. The formalization of the current US "War on Drugs".
Also an amusingly detailed description of buddha figures w/ #cannabis, #amphetamine, & #heroin in them.
@MichiganTrader2 I am literally just guessing at all of this. I have zero financial/educational/medical qualifications.
The company is responsive, so feel free to send them your Qs.
@MichiganTrader2 But tbh, I just now looked all of this up; I hadn't paid it much thought because I'm failing to mention the delivery method:
The microneedle patch, at the very minimum, would satisfy point 2- a novel delivery device.
So assuming that it works, I was thinking it's a 'moat.'
@MichiganTrader2 But there's a whole thing about the scope of coverage for MOT patents and compound patents. In a perfect world, the Phase II and III trials for PD-LID go well; the patented treatment method would be the protocol approved and then subsequently covered by insurers!
IIii think(?)
@DrBronner@MAPS Don't get me wrong, the sustainable sourcing and humanitarian outreach are the primary drivers for my overall perception of your company. +Bonus points for big bottle of effective, simple soap.
(But actually, I /buy/ it for the writing on the bottle)
@sportbettor51 Oh and it's worth mentioning for anyone feeling like they "missed the rocket," $phrrf is closely linked with $rvvtf, and the latter hasn't done the 'thing' yet since our lives are now secretly run by algorithms.
I have a stake in both, but I am a pauper.
(/not advisor, advice)
@sportbettor51 I got some inhibitors, too! Nobody likes me!
>Ketamine is not natural, and has serious side effects. This doesn't matter as much when faced with the severity of the targeted diseases, but you've got to remember that the point of further psychedelic research is to do /better/.
@sportbettor51 Next catalysts might be:
>TRD and some formulation of KetaBet (maybe on the MN platform?); look for a Phase II pre-IND meeting with the FDA
>ALS Phase II trials; also above
>Actual initiation of the PD-LID Phase II trials (I think I read Q3?)
@DrBronner "Fair trade certified" to me means that a reasonable effort was made to ensure that all parties that contributed to the production and distribution of the product have been compensated in an equitable manner.
Fluorescent tags attached to molecular cargo reveal the transport routes cells use to exchange signals in the developing nervous system
https://t.co/kFkkuiPRJf